InsiderTrades

Form 4 for DMAC DiaMedica Therapeutics Inc.

Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001235802-25-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-18 2025-02-13 DMAC Giuffre Randall Michael Dir M - OptEx $2.56 +17.0K 392.4K +5% +$43.6K
DM 2025-02-18 2025-02-13 DMAC Giuffre Randall Michael Dir M - OptEx $0.00 -17.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Voting Common Shares, no par value per share 2025-02-13 M A 12,000 $2.11 387,412 D — — (F1) Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually.
2 Common Voting Common Shares, no par value per share 2025-02-13 M A 5,000 $3.65 392,412 D — — (F1) Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually.
3 Derivative Stock Option (right to buy) 2025-02-13 M D 12,000 $0.00 0 D $2.11 · — to 2025-12-01 12,000 Common Shares (F3) This option has fully vested.
4 Derivative Stock Option (right to buy) 2025-02-13 M D 5,000 $0.00 0 D $3.65 · — to 2026-11-28 5,000 Common Shares (F3) This option has fully vested.